Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €39.54 and traded as high as €42.40. Fresenius Medical Care shares last traded at €41.31, with a volume of 1,412,291 shares changing hands.
Fresenius Medical Care Stock Performance
The stock’s 50-day simple moving average is €41.06 and its 200-day simple moving average is €39.55. The stock has a market cap of $12.43 billion, a price-to-earnings ratio of 18.87, a price-to-earnings-growth ratio of 0.42 and a beta of 0.94. The company has a current ratio of 1.07, a quick ratio of 0.80 and a debt-to-equity ratio of 87.31.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
See Also
- Five stocks we like better than Fresenius Medical Care
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
